common glp 1 agonist Understanding GLP-1 receptor agonists and their impact on drug discovery What Are GLP-1 Agonists For

From the Metabolic Syndrome to NAFLD or Vice Versa

1), S330 (2010)

2021;11:e504e507

Ongoing research is probing novel applications of GLP-1 agonists beyond diabetes and obesity from potential use in metabolic dysfunction-associated steatohepatitis (MASH) to trials investigating neuroprotective effects in conditions like Parkinsons and Alzheimers disease, though the 2025 phase 3 trials in both conditions failed to show clinical benefit ( [24] ) ( [25] 02808-3/fulltext))

Unlike semaglutide , which targets only the GLP-1 receptor, or tirzepatide , which targets GLP-1 and GIP receptors, retatrutide activates all three metabolic receptors at once

This patient information is based on a leaflet from the Faculty of Sexual and Reproductive Healthcare (FSRH) and the Primary Care Womens Health Society